InMed Pharmaceuticals, Inc. (INM)
0.8912
+0.01
(+1.27%)
USD |
NASDAQ |
Feb 25, 16:00
0.8992
+0.01
(+0.90%)
Pre-Market: 20:00
InMed Pharmaceuticals Free Cash Flow : -7.513M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -18.79M |
| Aurinia Pharmaceuticals, Inc. | 120.40M |
| Edesa Biotech, Inc. | -8.004M |
| Lexaria Bioscience Corp. | -8.775M |
| Xenon Pharmaceuticals, Inc. | -253.05M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.352M |
| Cash from Financing (Quarterly) | 0.0008M |
| Free Cash Flow Per Share (Quarterly) | -0.5947 |
| Free Cash Flow to Equity (Quarterly) | -2.243M |
| Free Cash Flow to Firm (Quarterly) | -2.352M |
| Free Cash Flow Yield | -306.3% |